These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18710625)
1. [Expression and clinical significance of a disintegrin and metalloprotease 8 (ADAM8) and epidermal growth factor receptor (EGFR) in non-small cell lung cancer]. Wu GC; Hu HC; Shi MH Ai Zheng; 2008 Aug; 27(8):874-8. PubMed ID: 18710625 [TBL] [Abstract][Full Text] [Related]
2. [Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer]. Chen XL; Zhang WG; Chen XY; Sun ZM; Liu SH Ai Zheng; 2006 Sep; 25(9):1134-7. PubMed ID: 16965657 [TBL] [Abstract][Full Text] [Related]
3. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil. Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586 [TBL] [Abstract][Full Text] [Related]
4. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
5. ADAM8 as a novel serological and histochemical marker for lung cancer. Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614 [TBL] [Abstract][Full Text] [Related]
6. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features]. Wang L; Li X; Li Y; Xue YW Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808 [TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer]. Zheng XY; Qi YM; Gao YF; Wang XY; Qi MX; Shi XF; An XL Ai Zheng; 2009 Jul; 28(7):679-84. PubMed ID: 19624891 [TBL] [Abstract][Full Text] [Related]
8. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer. Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543 [TBL] [Abstract][Full Text] [Related]
9. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma]. Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer. Wang D; Hao T; Pan Y; Qian X; Zhou D Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207 [TBL] [Abstract][Full Text] [Related]
11. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung. Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022 [TBL] [Abstract][Full Text] [Related]
12. [Expression of EGFR, survivn and hnRNPA2/B1 in bronchial brushing cytology specimens and their significance in diagnosis of lung cancer]. Lu SS; Pan QJ; Zhao LL; Guo HQ; Zhang ZH; Cao J Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):621-5. PubMed ID: 22325225 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features and prognostic implications of EGFR/c-Met gene copy number and protein expression in non-small cell lung cancer]. Ai T; Wang N; Li WW; Song LP Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):825-9. PubMed ID: 21223687 [TBL] [Abstract][Full Text] [Related]
14. Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer. Wen Q; Wang W; Chu S; Luo J; Chen L; Xie G; Xu L; Li M; Fan S PLoS One; 2015; 10(7):e0132190. PubMed ID: 26161893 [TBL] [Abstract][Full Text] [Related]
15. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer. Zhang J; Chen N; Qi J; Zhou B; Qiu X J Cancer Res Clin Oncol; 2014 Aug; 140(8):1441-9. PubMed ID: 24770635 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Cox G; Jones JL; O'Byrne KJ Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of Elf-1 and vascular endothelial growth factor in non-small cell lung cancer]. Yang DX; Han YC; Liu LY; Yu N; Wang X; Shi Y Ai Zheng; 2009 Jul; 28(7):762-7. PubMed ID: 19624906 [TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer]. Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995 [TBL] [Abstract][Full Text] [Related]
19. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer. Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440 [TBL] [Abstract][Full Text] [Related]
20. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]